Nilesh Chande Selected Research

Remission Induction

1/2021	Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review.
1/2018	Low dose naltrexone for induction of remission in Crohn's disease.
10/2016	Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
8/2015	Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
8/2014	Methotrexate for induction of remission in ulcerative colitis.
2/2014	Low dose naltrexone for induction of remission in Crohn's disease.
4/2013	Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
7/2012	Sargramostim (GM-CSF) for induction of remission in Crohn's disease: a cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials.
11/2011	Sargramostim (GM-CSF) for induction of remission in Crohn's disease.
9/2011	Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nilesh Chande Research Topics

Disease

25	Crohn Disease (Crohn's Disease) 01/2022 - 09/2005
16	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 09/2011
13	Ulcerative Colitis 01/2022 - 10/2010
6	Collagenous Colitis 11/2017 - 12/2004
5	Lymphocytic Colitis 01/2017 - 04/2007
4	Microscopic Colitis 03/2019 - 03/2005
4	Nausea 11/2017 - 08/2011
3	Pancreatitis 01/2021 - 05/2016
3	Inflammation (Inflammations) 12/2020 - 08/2013
3	Exanthema (Rash) 11/2017 - 08/2014
2	Necrosis 03/2019 - 03/2014
2	Marijuana Abuse (Cannabis Abuse) 11/2018 - 11/2018
2	Abdominal Pain (Pain, Abdominal) 11/2017 - 01/2017
2	Neck Pain (Cervicalgia) 11/2017 - 01/2017
2	Headache (Headaches) 11/2017 - 01/2017
2	Vomiting 11/2017 - 01/2017
2	Fistula 10/2016 - 04/2013
2	Thrombosis (Thrombus) 08/2015 - 10/2010
2	Hemorrhage 03/2014 - 03/2013
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Sclerosing Cholangitis 12/2020
1	Infections 12/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Dizziness (Lightheadedness) 11/2018
1	Weight Gain 11/2017
1	Hyperhidrosis 01/2017
1	Sleepiness 01/2017
1	Abscess 08/2014
1	Migraine Disorders (Migraine) 08/2014
1	Pneumonia (Pneumonitis) 08/2014
1	Hypoalbuminemia 08/2014
1	Alopecia (Baldness) 08/2014
1	Dyspepsia (Indigestion) 08/2014
1	Venous Thromboembolism 03/2013
1	Heart Failure 11/2011
1	Musculoskeletal Pain 11/2011
1	Pulmonary Edema 11/2011
1	Fever (Fevers) 11/2011
1	Chest Pain (Chest Pains) 11/2011
1	Capillary Leak Syndrome 11/2011
1	Dyspnea (Shortness of Breath) 11/2011

Drug/Important Bio-Agent (IBA)

8	Azathioprine (Imuran)FDA LinkGeneric 01/2021 - 09/2005
6	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2021 - 09/2005
6	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 09/2005
6	Budesonide (Pulmicort)FDA LinkGeneric 03/2019 - 12/2004
5	Mesalamine (Mesalazine)FDA LinkGeneric 01/2021 - 01/2009
5	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2018 - 06/2015
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 10/2009
4	AnticoagulantsIBA 08/2015 - 10/2010
3	Adalimumab (Humira)FDA Link 01/2022 - 03/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2014
3	Infliximab (Remicade)FDA Link 01/2022 - 11/2014
3	Biological ProductsIBA 12/2020 - 01/2016
3	CannabinoidsIBA 01/2020 - 11/2018
3	Pharmaceutical PreparationsIBA 01/2019 - 07/2010
3	C-Reactive ProteinIBA 11/2018 - 06/2015
3	Opioid Analgesics (Opioids)IBA 01/2018 - 02/2014
3	SteroidsIBA 10/2016 - 09/2005
3	Heparin (Liquaemin)FDA LinkGeneric 08/2015 - 10/2010
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2015 - 10/2010
2	Naltrexone (ReVia)FDA LinkGeneric 01/2018 - 02/2014
2	Prednisolone (Predate)FDA LinkGeneric 11/2017 - 01/2009
2	Cholestyramine Resin (Questran)FDA LinkGeneric 01/2017 - 01/2009
2	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 01/2017 - 01/2009
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2012 - 11/2011
2	sargramostim (Leukine)FDA Link 07/2012 - 11/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	ozanimodIBA 01/2022
1	CytokinesIBA 01/2022
1	Oncostatin MIBA 01/2022
1	GlucocorticoidsIBA 01/2021
1	HLA-DQA1 antigen (HLA DQA1)IBA 01/2021
1	2-mercaptopurineIBA 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 12/2020
1	IntegrinsIBA 12/2020
1	vedolizumabIBA 03/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Cytochrome P-450 CYP3AIBA 01/2019
1	CannabidiolIBA 11/2018
1	EndocannabinoidsIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	Beclomethasone (Beclometasone)FDA Link 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2016
1	LactoferrinIBA 06/2015
1	golimumab FDA Link 11/2014
1	Certolizumab Pegol FDA Link 11/2014
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2014
1	Prednisone (Sone)FDA LinkGeneric 05/2014
1	Monoclonal AntibodiesIBA 03/2014
1	Phenobarbital (Luminal)FDA Link 08/2013
1	ProdrugsIBA 08/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2012
1	EnzymesIBA 08/2011
1	CollagenIBA 04/2009

Therapy/Procedure

20	Therapeutics 01/2021 - 10/2010
12	Remission Induction 01/2021 - 09/2005
3	Biological Therapy 12/2020 - 01/2019
2	Liver Transplantation 12/2020 - 07/2006
1	Drug Therapy (Chemotherapy) 12/2015